Dr. Malik is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9609 Medical Centre Drive
Rockville, MD 20850Phone+1 202-744-1694
Education & Training
- George Washington UniversityFellowship, Hematology and Medical Oncology, 1994 - 1996
- MedStar Health/Georgetown University HospitalFellowship, Hematology and Medical Oncology, 1992 - 1994
- UPMC Medical EducationResidency, Internal Medicine, 1983 - 1986
- Government Medical College of Jammu and KashmireClass of 1979
Certifications & Licensure
- DC State Medical License 1996 - 2024
- VA State Medical License 2001 - 2024
- MD State Medical License 1996 - 2001
- PA State Medical License 1985 - 1992
- GA State Medical License 1984 - 1987
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Representativeness of Patients Enrolled in the Lung Cancer Master Protocol (Lung-MAP).Riha Vaidya, Joseph M Unger, Lu Qian, Katherine Minichiello, Roy S Herbst
JCO Precision Oncology. 2023-09-01 - 1 citationsClinical Trial Development in TP53-Mutated Locally Advanced and Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma.Cristina P Rodriguez, Hyunseok Kang, Jessica L Geiger, Barbara Burtness, Christine H Chung
Journal of the National Cancer Institute. 2022-12-08 - 32 citationsRates of Guideline-Concordant Surgery and Adjuvant Chemotherapy Among Patients With Early-Stage Lung Cancer in the US ALCHEMIST Study (Alliance A151216).Kenneth L Kehl, David Zahrieh, Ping Yang, Shauna L Hillman, Angelina D Tan
JAMA Oncology. 2022-05-01
Press Mentions
- Cetuximab with Radiation Found to Be Inferior to Standard Treatment in HPV-Positive Oropharyngeal CancerAugust 23rd, 2018
- Study: Cetuximab, Radiation Inferior to Standard HPV Throat Cancer TreatmentAugust 14th, 2018
- Women, Elderly, Minorities Poorly Represented in Lung Cancer Drug Trial Data Submitted to US FDAJuly 6th, 2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: